An accelerated radiotherapy scheme using a concomitant boost technique for the treatment of unresectable stage III non-small cell lung cancer

Japanese Journal of Clinical Oncology

Volumn 35, Issue 5, 2005, Pages 239-244

  Izmirli, Mustafa ^a   Yaman, Fuat ^b   Buyukpolat, M Yakup ^b   Yoney, Adnan ^b   Unsal, Mustafa ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Concomitant boost; Non small cell lung cancer; Radiation therapy

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUTROPENIA; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; SPINAL CORD DISEASE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; DISEASE FREE SURVIVAL; ESOPHAGUS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RADIATION EXPOSURE; SKIN; SPINAL CORD; SURVIVAL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ESOPHAGUS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SKIN; SPINAL CORD; SURVIVAL ANALYSIS;

EID: 21744437116     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi075     Document Type: Article

References (22)

1. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Cancer 1980;45:2744-53.
2. Perez CA, Pajak TF, Rubin P, et al. Long-term observation of the patterns of failure in patients with unresectable non-oat cell carcinoma of lung treated with definitive radiotherapy: Report by the Radiation Oncology Group. Cancer 1987;59:1874-81.
3. Perez CA, Stanley K, Grundy G, et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 1982;50:1091-9.
4. Wilson GD, Mcnally NJ, Dische S, et al. Measurement of cell kinetics in human tumors in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988;58:423-31.
5. Withers HR, Taylor JMG, Maciewjewski B, et al. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica 1988;27:131-46.
6. Fletcher GH. Clinical dose response curves of human malignant epithelial tumors. Br J Radiol 1973;46:1-12.
7. Chen M, Jiang GL, Fu XL, et al. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 2000;28:11-9.
8. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-46.
9. Moore DF, Lee JS. Staging and prognostic factors: Non-small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, editors. Lung cancer: principles and practice, first edition. Philadelphia, PA: Lippincott 1996;481-94.
10. Dosoretz DE, Galmarini D, Rubenstein JH, et al. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27:507-16.
11. Perez CA, Bauer M, Edelstein S, et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 1986;12:539-47.
12. Saunders MI, Barltrop MA, Rassa P, et al. The relationship between tumor response and survival following radiotherapy for carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1984;10:503-8.
13. Graham MV, James A, Purdy P, et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1995;33:993-1000.
14. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-54.
15. Arriagada R, LeChevalier T, Quoix E, et al. ASTRO plenary: Effects of chemotherapy on locally advanced non-small cell lung cancer: A randomized study of 353 patients. Int J Radiat Biol Phys 1991;20:1183-90.
16. Saunders M, Dische S, Barrett A, et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial (CHART steering committee). Radiother Oncol 1999;52:137-48.
17. Saunders M, Rojas A, Lyn B, et al. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small cell lung cancer. Br J Cancer 1998;78:1323-8.
18. Fu XL, Jiang GL, Wang LJ, et al. Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: Clinical phase I/II trial. Int J Radiat Oncol Biol Phys 1997;39:545-52.
19. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-9.
20. Curran WJ, Scott C, Langer C, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III non small cell lung cancer: RTOG 9410 (abstract). Proc Am Soc Clin Oncol 2003;22:621a.
21. Pierre F, Maurice P, Gilles R, et al. A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (GLOT-GFPC-NPC 95-01 study) (abstract). Proc Am Soc Clin Oncol 2001;20:312a.
22. Furuse K, Hosoe S, Masuda N, et al. Impact of tumor control on survival in unresectable stage III non-small cell lung cancer (NSCLC) treated with concurrent thoracic radiotherapy and chemotherapy (abstract). Proc Am Soc Clin Oncol 2000;19:484a.